Skip to Main Content
Back to News

Lobbying Update: $30,000 of CABOT CORPORATION lobbying was just disclosed

None

$30,000 of CABOT CORPORATION lobbying was just disclosed, from Q3 of 2025, in a new Lobbying Disclosure Act filing.

This included lobbying on issues like:

"Clean Air Issues"

You can find more data on corporate lobbying on Quiver Quantitative.

CBT Insider Trading Activity

CBT Insider Trades

CBT insiders have traded $CBT stock on the open market 4 times in the past 6 months. Of those trades, 0 have been purchases and 4 have been sales.

Here’s a breakdown of recent trading of $CBT stock by insiders over the last 6 months:

  • SEAN D KEOHANE (President and CEO) has made 0 purchases and 4 sales selling 114,436 shares for an estimated $9,072,094.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

CBT Hedge Fund Activity

We have seen 167 institutional investors add shares of CBT stock to their portfolio, and 215 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • FMR LLC removed 1,222,399 shares (-84.6%) from their portfolio in Q2 2025, for an estimated $91,679,925
  • FULLER & THALER ASSET MANAGEMENT, INC. added 978,297 shares (+82.1%) to their portfolio in Q2 2025, for an estimated $73,372,275
  • AQR CAPITAL MANAGEMENT LLC added 478,702 shares (+123.0%) to their portfolio in Q2 2025, for an estimated $35,902,650
  • BLACKROCK, INC. removed 285,903 shares (-4.1%) from their portfolio in Q2 2025, for an estimated $21,442,725
  • NORGES BANK added 273,729 shares (+65.8%) to their portfolio in Q2 2025, for an estimated $20,529,675
  • MORGAN STANLEY added 173,717 shares (+33.1%) to their portfolio in Q2 2025, for an estimated $13,028,775
  • AMERICAN CENTURY COMPANIES INC added 166,460 shares (+11.1%) to their portfolio in Q2 2025, for an estimated $12,484,500

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

CBT Price Targets

Multiple analysts have issued price targets for $CBT recently. We have seen 2 analysts offer price targets for $CBT in the last 6 months, with a median target of $85.0.

Here are some recent targets:

  • John Roberts from Mizuho set a target price of $88.0 on 10/03/2025
  • Joshua Spector from UBS set a target price of $82.0 on 08/05/2025

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles